Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Contact persons
Help
DOI
 |
|
Open Access Green as soon as Postprint is submitted to ZB.
Photodynamic diagnosis of early stage malignancies: preliminary results in urology and pneumonology.
Proc. SPIE 1641, 107-112 (1992)
On the basis of clinical protocols, phase II-studies have been started to evaluate photodynamic diagnosis for early visualization o cancer in bladder and lung. As tumor marker the fluorescent and photosensitizing polyporphyrin Photofrin II is used in a dose which has been proven to avoid photosensitization of the patients' skin. The drug is administered systemically in a concentration of mostly 0,4 mg/kg body weight. Fluorescence of Photofrin II in tissue is detected by an image-intensifying CCD camera coupled to endoscopes usually used in both medical disciplines. Video presentation of the marker fluorescence occurs with high contrast due to real-time image processing following two-wavelength excitation of the tissue with laser light. A keypoint of the new diagnostic method is the correlation of the fluorescence contrast and the histological examination of biopsies removed from these areas. As an examples, 87 biopsies have been taken from 17 patients suffering from bladder cancer. While all tumorous samples (n = 16) show strong fluorescence, about 30% of the biopsies are judged as false positive. A variety of premalignant diseases has been found in these sections. No false negative results have been obtained up to now.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Scientific Article
ISSN (print) / ISBN
0277-786X
e-ISSN
1996-756X
Journal
Proceedings of SPIE
Quellenangaben
Volume: 1641,
Pages: 107-112
Publisher
SPIE
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Laser laboratory (ZLL)